Investment Type: Purchase of Block in Public Company
Company Description:Founded in 1985, CMT has become a leading developer of digital x-ray acquisition technology. CMT sells its products through OEM agreements with global medical imaging manufacturers and directly to medical imaging centers through a network of over 100 distributors. Exports from Israel account for over 90% of CMT's sales.
Transaction:Shamrock acquired its stake in CMT from Paul Capital and worked with management to evaluate various global expansion opportunities.
Status: In September 2005, Shamrock executed a block sale of its position in CMT. This investment generated a 2x multiple on invested capital and a 35% IRR.
